By Kat Greene ( June 5, 2014, 9:06 PM EDT) -- Glenmark Pharmaceuticals Ltd. urged the Federal Circuit on Wednesday to reconsider its decision to uphold a $16 million jury verdict that found the generic-drug maker had infringed a patent owned by Abbott Laboratories for blood pressure medication Tarka, saying the plaintiffs in the suit weren't patentees entitled to receive damages....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.